Related Experiment Video
Updated: Jan 31, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
CTRP4 ameliorates dexamethasone‑induced insulin resistance through the IRS‑1/PI3K/AKT pathway in 3T3‑L1 adipocytes
Maireyanmu Rouzi1, Xi Sun1, Luguang Sheng1
1Department of Endocrinology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, P.R. China.
Abstract:
In 2022, the World Health Organization estimated that globally, ~2.5 billion adults were overweight, including 890 million individuals with obesity. Adipose tissue dysfunction in obese individuals is a key contributor to the pathogenesis of insulin resistance. Within the present study, the association between serum levels of C1q/TNF‑related protein 4 (CTRP4) and insulin resistance (IR) in overweight/obese patients was investigated and the effects and mechanisms of CTRP4 on IR in dexamethasone‑induced 3T3‑L1 adipocytes were evaluated. A total of 98 overweight/obese patients were enrolled in the present study. Serum CTRP4 concentration levels were measured with ELISA kits. Correlations between CTRP4 and the homeostatic model assessment of IR (HOMA‑IR) were evaluated using Spearman's correlation analysis. Recombinant CTRP4 protein was administered to fully differentiated 3T3‑L1 adipocytes to explore the impact of CTRP4 on lipid accumulation. In addition, the effects of CTRP4 on restoring impaired glucose uptake were examined through the glucose oxidase‑peroxidase method. Molecular marker expression levels in the insulin signaling pathway, in 3T3‑L1 adipocytes with IR induced by 1 µM dexamethasone, were also examined, through western blotting. The expression levels of CTRP4 exhibited a negative association with body mass index (r=‑0.35; P<0.001), HOMA‑IR (r=‑0.24; P=0.048), waist circumference (r=‑0.38; P<0.001) and abdomen circumference (r=‑0.39; P<0.001). Following treatment of cells with recombinant CTRP4, a significant reduction in lipid accumulation was observed in 3T3‑L1 adipocytes, alongside with an increase in the glucose uptake rate in dexamethasone‑induced 3T3‑L1 adipocytes (all, P<0.05). Furthermore, a marked elevation in the expression levels of insulin receptor substrate 1 (IRS‑1), PI3K and AKT phosphorylation and GLUT4 was observed in the IR model of 3T3‑L1 adipocytes. Serum CTRP4 concentration levels were negatively correlated with IR in overweight/obese patients. CTRP4 suppressed lipid accumulation and promoted glucose uptake through the IRS‑1/PI3K/AKT signaling pathway and caused increased GLUT4 expression in 3T3‑L1 adipocytes.8.
Insights
Serum CTRP4 levels are negatively associated with insulin resistance (IR) in overweight and obese individuals. CTRP4 treatment in adipocytes reduced lipid accumulation and improved glucose uptake via the IRS-1/PI3K/AKT pathway.
Area of Science:
- Endocrinology
- Metabolic Syndrome
- Molecular Biology
Background:
- Obesity affects over 2.5 billion adults globally, contributing to insulin resistance (IR).
- Adipose tissue dysfunction is a primary driver of IR pathogenesis in obesity.
- C1q/TNF-related protein 4 (CTRP4) role in metabolic health requires further elucidation.
Purpose of the Study:
- To investigate the association between serum CTRP4 levels and IR in overweight/obese patients.
- To evaluate the effects and mechanisms of CTRP4 on IR in a cellular model.
Main Methods:
- Serum CTRP4 levels measured by ELISA in 98 overweight/obese patients.
- Correlation analysis between CTRP4 and HOMA-IR (homeostatic model assessment of IR).
- In vitro study using dexamethasone-induced 3T3-L1 adipocytes to assess CTRP4 effects on lipid accumulation, glucose uptake, and insulin signaling pathway markers (IRS-1, PI3K, AKT, GLUT4) via western blotting.
Main Results:
- Serum CTRP4 levels showed a negative correlation with BMI, HOMA-IR, waist, and abdomen circumference.
- CTRP4 treatment significantly reduced lipid accumulation and increased glucose uptake in 3T3-L1 adipocytes.
- CTRP4 elevated IRS-1, PI3K and AKT phosphorylation, and GLUT4 expression in IR adipocytes.
Conclusions:
- Serum CTRP4 concentration is negatively correlated with insulin resistance in overweight/obese individuals.
- CTRP4 demonstrates potential therapeutic effects by suppressing lipid accumulation and promoting glucose uptake.
- CTRP4 exerts its effects through the IRS-1/PI3K/AKT signaling pathway, enhancing GLUT4 expression in adipocytes.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
09:20An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Insulin: The Receptor and Signaling Pathways
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Insulin Secretory Vesicles
Resistivity
Resistance